Obviousness Inquiry after Ksr
نویسندگان
چکیده
One of the most important and delicate judicial tasks in patent law is to keep the obviousness doctrine in reasonable working order. There are several reasons why the obviousness doctrine has been the subject of frequent judicial tinkering. First, patentability doctrines interact with each other, so doctrinal alterations that seem to be entirely external to the obviousness doctrine frequently have ripple effects on obviousness. The interaction between the utility and obviousness doctrines provides one good example. Second, the obviousness doctrine is internally complex. Cases in the chemical and biotechnology areas over the past several decades have amply illustrated this point. This Article examines Chief Judge Rader’s contributions to the task of tuning the obviousness doctrine, with particular attention to cases that have arisen after the Supreme Court’s pronouncements on obviousness in KSR v. Teleflex. * Robert A. Lucas Chair in Law and Director, Center for Intellectual Property Research, Indiana University Maurer School of Law, Bloomington, Indiana, [email protected]. 336 WASHINGTON JOURNAL OF LAW, TECHNOLOGY & ARTS [VOL. 7:4
منابع مشابه
KSR v. Teleflex. Part 1: Impact of U.S Supreme Court Patent Law on Canadian intellectual property and regulatory rights landscape.
In KSR, SCOTUS retooled the standard for obviousness to bring it back in line with the court's previous decisions in Hotchkiss and Graham. A comparative review of the law of obviousness in the United States and Canada, and its relation to innovation and competition, was undertaken in Sections II and III. The focal point of observed differences is the inherent creativity and inventiveness of the...
متن کاملA New Formula for Analyzing Formulation-patent Obviousness
The generic drug industry, which is estimated to save American consumers $10 billion a year,1 owes much of its current market success to Congress’s enactment of the Hatch-Waxman Act in 1984.2 The Hatch-Waxman Act sought to achieve a delicate balance, one where Americans could obtain unprecedented access to low-cost prescription medicine without somehow undermining the incentive of brand name dr...
متن کاملNot All Patents Are Created Equal: Bias against Predictable Arts Patents in the Post-ksr Landscape
Investment in intellectual property is considered a shrewd business strategy. However, companies that invest heavily in patenting the results of research and development may later be surprised by their inability to generate revenue from their patent portfolios. This is because those seeking to enforce patents in the predictable arts may find themselves stymied by recent developments in patent j...
متن کاملKSR: Have Gene Patents Been KO'd? The Non-Obviousness Determination of Patents Claiming Nucleotide Sequences When the Prior Art Has Already Disclosed the Amino Acid Sequence
متن کامل
"Obvious to try": a proper patentability standard in the pharmaceutical arts?
Pharmaceutical research often entails making small modifications to candidate drug molecules—modifications that might be deemed “obvious to try”—and then studying the largely unpredictable, yet critical, resulting biological effects. Recognizing this characteristic unpredictability, the U.S. Court of Appeals for the Federal Circuit has traditionally upheld the patentability of obvious-to-try ph...
متن کامل